drugset / Trial / NCT02560610
Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim is to study the effect of OC000459 on eosinophilic airway inflammation and asthma control in subjects with severe, refractory eosinophilic asthma.
Timeline
- Start
- 2016-09
- Primary completion
- 2018-08-02
- Completion
- 2018-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TIMAPIPRANT | Small molecule | 50 mg | Oral |